Quantcast

Actos Whistleblower Lawsuit Alleges Takeda Pharmaceuticals Attempted to Influence Reports of Risks of Actos Side Effects, the Consumer Justice Foundation Reports

March 19, 2012

The Consumer Justice Foundation, a for-profit corporation whose web site URL can be found at http://www.sideeffectsrx.com is staffed by a team of professional consumer advocates whose mission is to alert the public of the potential dangers of certain prescription drugs by way of free online information resources. The CJF hereby alerts the public of an Actos whistleblower lawsuit that alleges that Takeda Pharmaceuticals, the manufacturer of diabetes drub Actos, influenced reports of risks of Actos side effects as the drug came under scrutiny around the world.

(PRWEB) March 19, 2012

The Consumer Justice Foundation, a for-profit corporation staffed by a team of professional consumer advocates dedicated to alerting the public of the potential dangers of certain prescription medications by way of free online informational resources, hereby alerts the public of allegations made in an Actos whistleblower lawsuit that accuse Takeda Pharmaceuticals, the manufacturer of Actos, of influencing reports of risks of potential Actos side effects.

Specifically, this Actos whistleblower lawsuit, which is known as U.S. ex rel. Helen Ge v. Takeda Pharmaceutical Co., 10-cv-11043, U.S. District Court, District of Massachusetts (Boston), concerns a former employee of Takeda Pharmaceuticals who filed this lawsuit the federal False Claims Act. The plaintiff, Helen Ge, alleges that the manufacturer wanted to scuttle findings that this diabetes medication exacerbated heart failure for some who used it.

Ms. Ge alleges that when Actos side effects became a public issue and the drug came under scrutiny, executives at Takeda Pharmaceuticals attempted to direct medical reviewers, which was Ms. Ge´s role at the company at the time, to “change their professional opinion” regarding the potential dangers of Actos side effects with regards to heart problems. Ms. Ge further alleges that when she raised concerns regarding this request, she was terminated.

Actos was approved for use in the United States by the FDA in 1999 for treatment of symptoms relating to type 2 diabetes, and since then it has been banned from use in both Germany and France because of the potential risk of long-term Actos users to contract bladder cancer. On June 15, 2011, the FDA published a public warning alerting long-term American users of Actos of the same risk.

About the Consumer Justice Foundation    

The Consumer Justice Foundation, whose Web site can be found at http://www.consumerjusticefoundation.com, is a for-profit organization that serves two purposes for consumers: (1) to provide educational information regarding the policies and procedures of large corporations and how they affect the average consumer; and (2) to provide news updates and resources that continue to update consumers regarding developments taken by corporations that include pharmaceutical drug companies, auto manufacturers and insurance companies so that consumers who have been harmed can use these informational resources to connect to an experienced professional who can help them. The team at the Consumer Justice Foundation is staffed by experienced and passionate consumer advocates whose mission is to raise the awareness of issues that could pose a risk of harm to those who may not otherwise be aware of the dangers they face.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/3/prweb9296926.htm


Source: prweb



comments powered by Disqus